Literature DB >> 32087235

Kinin B1 receptor: A target for neuroinflammation in hypertension.

Srinivas Sriramula1.   

Abstract

Kinins are a family of oligopeptides of the kallikrein-kinin system that act as potent vasoactive hormones and inflammatory mediators. The bioactive kinins mainly consist of bradykinin and kallidin, and their metabolites des-Arg9-bradykinin and des-Arg10-kallidin. Physiological effects of kinins are mediated by activation of highly selective G-protein coupled kinin B1 and B2 receptors. Growing evidence suggests that B1 receptor activation mediates diverse physiological and pathological features of cardiovascular diseases. However, studies are limited regarding the impact of B1 receptor mediated neuroinflammation on the development of hypertension and other cardiovascular diseases. Given the potential role for B1 receptor activation in immune cell infiltration, microglia activation, and cytokine production within the central nervous system, B1 receptor mediated signaling cascades might result in elevated neuroinflammation. In this review, we will discuss the potential pro-inflammatory role of B1 receptor activation in hypertension. A better understanding of B1 receptor inflammatory signaling may lead to the development of therapeutics that target B1 receptors to treat neurogenic hypertension.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiotensin (1–7) (PubChem CID: 71434130); Angiotensin II (PubChem CID: 172198); Central nervous system; Hypertension; Inflammation; Kinin B1 receptor; R-954 (PubChem CID: 101865250); R715 (PubChem CID: 5311397); RAS; SSR240612 (PubChem CID: 44235958)

Mesh:

Substances:

Year:  2020        PMID: 32087235     DOI: 10.1016/j.phrs.2020.104715

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  8 in total

Review 1.  Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Cardiovascular Diseases.

Authors:  Menglong Wang; Wei Pan; Yao Xu; Jishou Zhang; Jun Wan; Hong Jiang
Journal:  J Inflamm Res       Date:  2022-05-25

2.  Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.

Authors:  Erkan Cure; Medine Cumhur Cure; Hulya Vatansev
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Oct-Dec       Impact factor: 1.636

3.  Activation of Kinin B1R Upregulates ADAM17 and Results in ACE2 Shedding in Neurons.

Authors:  Rohan Umesh Parekh; Srinivas Sriramula
Journal:  Int J Mol Sci       Date:  2020-12-25       Impact factor: 5.923

4.  COVID-19 and Lung Mast Cells: The Kallikrein-Kinin Activation Pathway.

Authors:  Seigo Nagashima; Anderson Azevedo Dutra; Mayara Pezzini Arantes; Rafaela Chiuco Zeni; Carolline Konzen Klein; Flávia Centenaro de Oliveira; Giulia Werner Piper; Isadora Drews Brenny; Marcos Roberto Curcio Pereira; Rebecca Benicio Stocco; Ana Paula Camargo Martins; Eduardo Morais de Castro; Caroline Busatta Vaz de Paula; Andréa Novaes Moreno Amaral; Cleber Machado-Souza; Cristina Pellegrino Baena; Lucia Noronha
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923

5.  Hypothalamic kinin B1 receptor mediates orexin system hyperactivity in neurogenic hypertension.

Authors:  Rohan Umesh Parekh; Acacia White; Korin E Leffler; Vinicia C Biancardi; Jeffrey B Eells; Abdel A Abdel-Rahman; Srinivas Sriramula
Journal:  Sci Rep       Date:  2021-10-26       Impact factor: 4.996

Review 6.  Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.

Authors:  Masoumeh Farahani; Zahra Niknam; Leila Mohammadi Amirabad; Nasrin Amiri-Dashatan; Mehdi Koushki; Mohadeseh Nemati; Fahima Danesh Pouya; Mostafa Rezaei-Tavirani; Yousef Rasmi; Lobat Tayebi
Journal:  Biomed Pharmacother       Date:  2021-11-12       Impact factor: 7.419

7.  Tissue Kallikrein Protects Rat Prostate against the Inflammatory Damage in a Chronic Autoimmune Prostatitis Model via Restoring Endothelial Function in a Bradykinin Receptor B2-Dependent Way.

Authors:  Mengyang Zhang; Dongxu Lin; Changcheng Luo; Pengyu Wei; Kai Cui; Zhong Chen
Journal:  Oxid Med Cell Longev       Date:  2022-02-01       Impact factor: 6.543

Review 8.  Function and structure of bradykinin receptor 2 for drug discovery.

Authors:  Jin-Kang Shen; Hai-Tao Zhang
Journal:  Acta Pharmacol Sin       Date:  2022-09-08       Impact factor: 7.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.